|
New treatment for severe asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com In early November, FDA approved mepolizumab (Nucala—GlaxoSmithKline), a novel treatment for severe asthma. This new treatment is an interleukin-5 (IL-5) antagonist that works by inhibiting IL-5 signaling, with subsequent reduction in the production … |
View full post on asthma – Google News